1. Home
  2. PMCB vs ABVE Comparison

PMCB vs ABVE Comparison

Compare PMCB & ABVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMCB
  • ABVE
  • Stock Information
  • Founded
  • PMCB 1996
  • ABVE 2019
  • Country
  • PMCB United States
  • ABVE Canada
  • Employees
  • PMCB N/A
  • ABVE N/A
  • Industry
  • PMCB Biotechnology: Biological Products (No Diagnostic Substances)
  • ABVE Packaged Foods
  • Sector
  • PMCB Health Care
  • ABVE Consumer Staples
  • Exchange
  • PMCB Nasdaq
  • ABVE Nasdaq
  • Market Cap
  • PMCB 13.9M
  • ABVE 13.4M
  • IPO Year
  • PMCB N/A
  • ABVE N/A
  • Fundamental
  • Price
  • PMCB $1.64
  • ABVE $0.47
  • Analyst Decision
  • PMCB
  • ABVE
  • Analyst Count
  • PMCB 0
  • ABVE 0
  • Target Price
  • PMCB N/A
  • ABVE N/A
  • AVG Volume (30 Days)
  • PMCB 57.4K
  • ABVE 106.3K
  • Earning Date
  • PMCB 12-13-2024
  • ABVE 11-22-2024
  • Dividend Yield
  • PMCB N/A
  • ABVE N/A
  • EPS Growth
  • PMCB N/A
  • ABVE N/A
  • EPS
  • PMCB 0.54
  • ABVE N/A
  • Revenue
  • PMCB N/A
  • ABVE $275,376,450.00
  • Revenue This Year
  • PMCB N/A
  • ABVE N/A
  • Revenue Next Year
  • PMCB N/A
  • ABVE N/A
  • P/E Ratio
  • PMCB $3.06
  • ABVE N/A
  • Revenue Growth
  • PMCB N/A
  • ABVE N/A
  • 52 Week Low
  • PMCB $1.39
  • ABVE $0.34
  • 52 Week High
  • PMCB $2.58
  • ABVE $4.07
  • Technical
  • Relative Strength Index (RSI)
  • PMCB 40.27
  • ABVE N/A
  • Support Level
  • PMCB $1.72
  • ABVE N/A
  • Resistance Level
  • PMCB $1.94
  • ABVE N/A
  • Average True Range (ATR)
  • PMCB 0.17
  • ABVE 0.00
  • MACD
  • PMCB -0.01
  • ABVE 0.00
  • Stochastic Oscillator
  • PMCB 9.27
  • ABVE 0.00

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

About ABVE Above Food Ingredients Inc. Common Stock

Above Food Ingredients Inc is a differentiated, regenerative ingredient company. Its products are made with real nutritious, flavorful ingredients and delivered with transparency. Its vision is to create a healthier world one seed, one field, and one bite at a time. With a robust chain of custody of plant proteins, enabled by scaled operations and infrastructure in primary agriculture and processing, and proprietary seed development capabilities that leverage the power of artificial intelligence driven genomics. The company delivers nutritious foods to businesses and consumers with traceability and sustainability. Above Food's consumer products and brands are available in grocers across Canada and the United States.

Share on Social Networks: